glucagon retatrutide and LDL Cholesterol: How GLP-1 Medications Lower Heart Dis – Revolution Health & Wellness Retatrutide – 24mg – Prime

The peptides just revealed it sooner

Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. Journal of thrombosis and haemostasis : JTH vol

The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction

Drawing on her years of experience as a former plan sponsor and pharmacy director, Bridget unpacks the reality of modern PBM contracts, breaks down why lower rebates can actually be a positive signal for plan sponsors, how the biosimilar pipeline is reshaping the market, and what to watch out for as GLP-1 medications expand their indications

International Journal of Pharmaceutical Compounding